Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy

Natalizumab is an approved medication for highly active multiple sclerosis (MS). Progressive multifocal leukoencephalopathy (PML) may occur as a severe side effect of this drug. Here, we describe pathological and radiological characteristics of immune reconstitution inflammatory syndrome (IRIS), whi...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Metz, Imke, Radue, Ernst-Wilhelm, Oterino, Agustin, Kümpfel, Tania, Wiendl, Heinz, Schippling, Sven, Kuhle, Jens, Sahraian, Mohammad Ali, Gray, Francoise, Jakl, Veronika, Häusler, Darius, Brück, Wolfgang
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer-Verlag 2011
Pynciau:
Original Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3259335/
https://ncbi.nlm.nih.gov/pubmed/22057786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00401-011-0900-5
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg